Pharmaceutical CRDMO Services Market
完整報告名稱與涵蓋範圍
Pharmaceutical CRDMO Services Market Size, Share & Trends Analysis Report By Type (Small molecular CRDMO service, Middle molecular CRDMO service, Large molecular CRDMO service, By Application (Oncology, Central Nervous System (CNS), Cardiovascular, Infectious Diseases, Hematology, Vaccine), By Region, And By Segment Forecasts, 2024-2031.
報告摘要
With a 2023 valuation of USD 114.8 billion, the global Pharmaceutical CRDMO Services Market is set to progress to USD 266.7 billion by 2031, demonstrating a CAGR of 11.3% during the 2024–2031 forecast window.
At its core, Pharmaceutical CRDMO Services pertains to landscape are expandingly turning to these solutions to meet contemporary demands.
Growth is underpinned by a convergence of factors: rising awareness among end users, continuous product innovation, and the expanding emphasis on efficiency and sustainability within the healthcare sector.
From a segmentation standpoint, the market is categorized across multiple dimensions including product type, application, end-user, and geography, each exhibiting distinct growth patterns and opportunities.
From a regional perspective, mature markets in North America and Europe continue to hold considerable shares, while the Asia-Pacific region is gaining momentum through accelerated economic development and expanding investment in the sector.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Pharmaceutical CRDMO Service Market Snapshot
Chapter 4. Global Pharmaceutical CRDMO Service Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Type Estimates & Trend Analysis
5.1. by Type & Market Share, 2019 & 2031
5.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Type:
5.2.1. Small Molecule CRDMO Service
5.2.2. Middle Molecule CRDMO Service
5.2.3. Large Molecule CRDMO Service
Chapter 6. Market Segmentation 2: by Application Estimates & Trend Analysis
6.1. by Application & Market Share, 2019 & 2031
6.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Application:
6.2.1. Oncology
6.2.2. Infectious Disease
6.2.3. Neurology
6.2.4. Immunology
6.2.5. Hematology
6.2.6. Vaccine
Chapter 7. Pharmaceutical CRDMO Service Market Segmentation 3: Regional Estimates & Trend Analysis
7.1. North America
7.1.1. North America Pharmaceutical CRDMO Service Market Revenue (US$ Million) Estimates and Forecasts by Type, 2023-2031
7.1.2. North America Pharmaceutical CRDMO Service Market Revenue (US$ Million) Estimates and Forecasts by Application, 2023-2031
7.1.3. North America Pharmaceutical CRDMO Service Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
7.2. Europe
7.2.1. Europe Pharmaceutical CRDMO Service Market Revenue (US$ Million) Estimates and Forecasts by Type, 2023-2031
7.2.2. Europe Pharmaceutical CRDMO Service Market Revenue (US$ Million) Estimates and Forecasts by Application, 2023-2031
7.2.3. Europe Pharmaceutical CRDMO Service Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
7.3. Asia Pacific
7.3.1. Asia Pacific Pharmaceutical CRDMO Service Market Revenue (US$ Million) Estimates and Forecasts by Type, 2023-2031
7.3.2. Asia Pacific Pharmaceutical CRDMO Service Market Revenue (US$ Million) Estimates and Forecasts by Application, 2023-2031
7.3.3. Asia Pacific Pharmaceutical CRDMO Service Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
7.4. Latin America
7.4.1. Latin America Pharmaceutical CRDMO Service Market Revenue (US$ Million) Estimates and Forecasts by Type, 2023-2031
7.4.2. Latin America Pharmaceutical CRDMO Service Market Revenue (US$ Million) Estimates and Forecasts by Application, 2023-2031
7.4.3. Latin America Pharmaceutical CRDMO Service Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
7.5. Middle East & Africa
7.5.1. Middle East & Africa Pharmaceutical CRDMO Service Market Revenue (US$ Million) Estimates and Forecasts by Type, 2023-2031
7.5.2. Middle East & Africa Pharmaceutical CRDMO Service Market Revenue (US$ Million) Estimates and Forecasts by Application, 2023-2031
7.5.3. Middle East & Africa Pharmaceutical CRDMO Service Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
Chapter 8. Competitive Landscape
8.1. Major Mergers and Acquisitions/Strategic Alliances
8.2. Company Profiles
8.2.1. BioDuro-Sundia
8.2.2. Sai Life Sciences
8.2.3. Icosagen
8.2.4. WuXi Biologics
8.2.5. WuXi AppTec
8.2.6. Esco Aster
8.2.7. Jubilant Biosys
8.2.8. Syngene International
8.2.9. Chemveda
8.2.10. Ardena Holding
8.2.11. Eurofins
8.2.12. Jiangsu HUAYI Technology Co., Ltd.
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們